HCW Biologics Inc.(HCWB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HCWB HCW Biologics Inc.

未开盘 03-20 16:00:00 EDT

0.7385

-0.0140

-1.86%

盘后0.6775

-0.0610-8.26%

19:59 EDT

最高0.7888	最低0.7000	成交量116.11万
今开0.7258	昨收0.7525	日振幅11.80%
总市值259.72万	流通市值212.92万	总股本351.68万
成交额85.52万	换手率40.27%	流通股本288.32万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HCWB","market":"US","secType":"STK","nameCN":"HCW Biologics Inc.","latestPrice":0.7385,"timestamp":1774036800000,"preClose":0.7525,"halted":0,"volume":1161060,"hourTrading":{"tag":"盘后","latestPrice":0.6775,"preClose":0.7385,"latestTime":"19:59 EDT","volume":74108,"amount":50824.513796,"timestamp":1774051190940,"change":-0.061,"changeRate":-0.0826,"amplitude":0.0826},"delay":0,"changeRate":-0.01860465116279057,"floatShares":2883200,"shares":3516800,"eps":-13.81,"marketStatus":"未开盘","change":-0.014,"latestTime":"03-20 16:00:00 EDT","open":0.7258,"high":0.7888,"low":0.7,"amount":855171.892746,"amplitude":0.118007,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-13.81,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":0,"adr":0,"listingDate":1626753600000,"exchange":"NASDAQ","adjPreClose":0.7525,"preHourTrading":{"tag":"盘前","latestPrice":0.7294,"preClose":0.7525,"latestTime":"09:26 EDT","volume":86567,"amount":63441.246635,"timestamp":1774013198778,"change":-0.0231,"changeRate":-0.030698,"amplitude":0.063123},"postHourTrading":{"tag":"盘后","latestPrice":0.6775,"preClose":0.7385,"latestTime":"19:59 EDT","volume":74108,"amount":50824.513796,"timestamp":1774051190940,"change":-0.061,"changeRate":-0.0826,"amplitude":0.0826},"volumeRatio":0.011807398982417191},"requestUrl":"/m/hq/s/HCWB","defaultTab":"news","newsList":[{"id":"1170741138","title":"HCW Biologics Inc.获得HCW11-006融合免疫疗法全球独家授权，潜力巨大","url":"https://stock-news.laohu8.com/highlight/detail?id=1170741138","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170741138?lang=zh_cn&edition=full","pubTime":"2026-03-17 19:53","pubTimestamp":1773748419,"startTime":"0","endTime":"0","summary":"HCW Biologics Inc.已成功完成对HCW11-006的全球独家授权协议，这是一款具有高度潜力的融合免疫疗法药物。该协议的签署标志着公司在免疫治疗领域的战略布局迈出关键一步，有望为未来的产品管线注入强劲动力。HCW11-006作为一种创新的融合免疫疗法，在临床前研究中展现出显著的治疗前景，其独特的作用机制可能为相关疾病患者提供新的治疗选择。此次全球独家授权的达成，不仅巩固了HCW Biologics Inc.在生物制药领域的竞争优势，也为公司后续的研发和商业化进程奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","HCWB"],"gpt_icon":0},{"id":"2617958593","title":"Hcw Biologics Inc.盘中异动 早盘急速下跌8.33%报0.605美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617958593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617958593?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:43","pubTimestamp":1772635408,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日22时43分，Hcw Biologics Inc.股票出现波动，股价快速下跌8.33%。截至发稿，该股报0.605美元/股，成交量1.7606万股，换手率0.31%，振幅1.32%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304224328a6a29b99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304224328a6a29b99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","HCWB"],"gpt_icon":0},{"id":"1156059587","title":"HCW Biologics Inc. 收到纳斯达克决定函，重获符合所有持续上市规则资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1156059587","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156059587?lang=zh_cn&edition=full","pubTime":"2026-03-02 21:02","pubTimestamp":1772456528,"startTime":"0","endTime":"0","summary":"HCW Biologics Inc. 已成功恢复对纳斯达克所有持续上市规则的合规状态，这一结果已通过纳斯达克官方决定函予以确认。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","HCWB"],"gpt_icon":0},{"id":"2613731785","title":"Hcw Biologics Inc.盘中异动 股价大涨5.94%报0.613美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613731785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613731785?lang=zh_cn&edition=full","pubTime":"2026-02-23 22:32","pubTimestamp":1771857124,"startTime":"0","endTime":"0","summary":"北京时间2026年02月23日22时32分，Hcw Biologics Inc.股票出现波动，股价大幅上涨5.94%。截至发稿，该股报0.613美元/股，成交量5707股，换手率0.17%，振幅0.00%。Hcw Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223223204a7163236&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223223204a7163236&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","HCWB"],"gpt_icon":0},{"id":"2612266023","title":"Hcw Biologics Inc.盘中异动 早盘急速拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612266023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612266023?lang=zh_cn&edition=full","pubTime":"2026-02-19 22:55","pubTimestamp":1771512928,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日22时55分，Hcw Biologics Inc.股票出现波动，股价大幅上涨5.56%。Hcw Biologics Inc.股票所在的生物技术行业中，整体跌幅为1.29%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219225529a4b3a3f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219225529a4b3a3f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","HCWB"],"gpt_icon":0},{"id":"1147630657","title":"HCW生物制药宣布150万美元后续发行定价 按纳斯达克规则以市价发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1147630657","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147630657?lang=zh_cn&edition=full","pubTime":"2026-02-18 10:53","pubTimestamp":1771383224,"startTime":"0","endTime":"0","summary":"佛罗里达州米拉马尔，2026年2月17日——临床阶段生物制药公司HCW Biologics Inc.今日公布其后续发行的定价细节。此次发行将按纳斯达克规则以市价进行，共计发行2,477,292个单位，每个单位认购价格为0.6055美元。该认股权证的行权价为每股0.6055美元，将在获得股东批准后即可行权，并于股东批准之日起五年后到期。构成单位的普通股与认股权证可立即分离，并将在本次发行中分别发行。本次发行预计于2026年2月19日左右完成，具体时间取决于满足惯例交割条件。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","QQQE","BK4588","QQQJ","SQQQ","QQQ","TM","BK4099","QQQY","BK4555","03160","NDX","JEPQ","GPIQ","BK4139","BK4539","USAW.SI","TQQQ","BK4604","NVIW.SI","USJW.SI","NQmain","QYLG","QYLD","QQQM","PSQ","BK4585","HCWB","QID","MNQmain","TSYW.SI","QLD"],"gpt_icon":1},{"id":"1151660018","title":"HCW Biologics 宣布定价150万美元后续增发 按纳斯达克规则以市价发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1151660018","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151660018?lang=zh_cn&edition=full","pubTime":"2026-02-18 10:51","pubTimestamp":1771383071,"startTime":"0","endTime":"0","summary":"HCW Biologics Inc. 已确定其后续公开发行的定价，此次融资规模达150万美元。根据纳斯达克相关规定，本次发行采用市价定价机制进行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCWB","BK4539","BK4139"],"gpt_icon":0},{"id":"1125323790","title":"HCW Biologics与Wy Biotech宣布新合资公司Trimmune首轮融资完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1125323790","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125323790?lang=zh_cn&edition=full","pubTime":"2026-02-13 21:31","pubTimestamp":1770989471,"startTime":"0","endTime":"0","summary":"HCW Biologics与Wy Biotech共同宣布，双方新成立的合资企业Trimmune已顺利完成首轮融资。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","HCWB"],"gpt_icon":0},{"id":"2610066377","title":"Hcw Biologics Inc.盘中异动 股价大涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610066377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610066377?lang=zh_cn&edition=full","pubTime":"2026-02-10 00:41","pubTimestamp":1770655283,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日00时41分，Hcw Biologics Inc.股票出现波动，股价快速上涨5.77%。Hcw Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210004124a6e6de3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210004124a6e6de3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","HCWB"],"gpt_icon":0},{"id":"2609583885","title":"Hcw Biologics Inc.盘中异动 股价大跌5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609583885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609583885?lang=zh_cn&edition=full","pubTime":"2026-02-05 23:03","pubTimestamp":1770303782,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日23时03分，Hcw Biologics Inc.股票出现波动，股价急速下挫5.70%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205230302a480c376&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205230302a480c376&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","HCWB"],"gpt_icon":0},{"id":"2604949384","title":"Hcw Biologics Inc.盘中异动 早盘急速上涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604949384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604949384?lang=zh_cn&edition=full","pubTime":"2026-01-16 22:38","pubTimestamp":1768574339,"startTime":"0","endTime":"0","summary":"北京时间2026年01月16日22时38分，Hcw Biologics Inc.股票出现异动，股价急速上涨5.25%。Hcw Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116223859953d1930&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116223859953d1930&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","HCWB"],"gpt_icon":0},{"id":"2594211420","title":"Hcw Biologics Inc.盘中异动 急速下跌6.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594211420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594211420?lang=zh_cn&edition=full","pubTime":"2025-12-27 01:53","pubTimestamp":1766771622,"startTime":"0","endTime":"0","summary":"北京时间2025年12月27日01时53分，Hcw Biologics Inc.股票出现波动，股价快速下挫6.73%。Hcw Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251227015342953bb4f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251227015342953bb4f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","HCWB"],"gpt_icon":0},{"id":"1105799590","title":"HCW Biologics启动首个针对自身免疫疾病的HCW9302人类临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1105799590","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105799590?lang=zh_cn&edition=full","pubTime":"2025-11-18 20:25","pubTimestamp":1763468744,"startTime":"0","endTime":"0","summary":"HCW Biologics启动首个针对自身免疫疾病的HCW9302人类临床试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCWB","BK4139","BK4539"],"gpt_icon":0},{"id":"2584757620","title":"Hcw Biologics Inc.盘中异动 早盘急速下挫13.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584757620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584757620?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:31","pubTimestamp":1763389889,"startTime":"0","endTime":"0","summary":"北京时间2025年11月17日22时31分，Hcw Biologics Inc.股票出现波动，股价大幅下跌13.00%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117223129976f113e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117223129976f113e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB","BK4539","BK4139"],"gpt_icon":0},{"id":"2575093277","title":"Hcw Biologics Inc.盘中异动 早盘股价大涨5.69%报4.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575093277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575093277?lang=zh_cn&edition=full","pubTime":"2025-10-14 23:28","pubTimestamp":1760455698,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日23时28分，Hcw Biologics Inc.股票出现波动，股价大幅上涨5.69%。截至发稿，该股报4.46美元/股，成交量1.9525万股，换手率0.91%，振幅5.45%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014232818a45fd739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014232818a45fd739&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","HCWB","BK4139"],"gpt_icon":0},{"id":"2518227454","title":"Hcw Biologics Inc.盘中异动 急速下挫5.94%报0.343美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227454?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615237,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，Hcw Biologics Inc.股票出现波动，股价急速跳水5.94%。截至发稿，该股报0.343美元/股，成交量4391股，换手率0.01%，振幅4.46%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220037abf3078a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220037abf3078a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","HCWB"],"gpt_icon":0},{"id":"2517190600","title":"Hcw Biologics Inc.盘中异动 临近收盘股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517190600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517190600?lang=zh_cn&edition=full","pubTime":"2025-03-07 04:36","pubTimestamp":1741293412,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日04时36分，Hcw Biologics Inc.股票出现波动，股价快速拉升5.31%。Hcw Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.93%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9302旨在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307043652abebcfc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307043652abebcfc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","HCWB"],"gpt_icon":0},{"id":"2517097944","title":"Hcw Biologics Inc.盘中异动 急速下挫6.67%报0.333美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517097944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517097944?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:01","pubTimestamp":1741194064,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时01分，Hcw Biologics Inc.股票出现波动，股价大幅下挫6.67%。截至发稿，该股报0.333美元/股，成交量10.5127万股，换手率0.24%，振幅3.92%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为1.17%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306010104abe9dd54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306010104abe9dd54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","HCWB"],"gpt_icon":0},{"id":"2516365677","title":"Hcw Biologics Inc.盘中异动 早盘股价大跌6.89%报0.354美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516365677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516365677?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098748,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Hcw Biologics Inc.股票出现波动，股价急速下跌6.89%。截至发稿，该股报0.354美元/股，成交量2.562万股，换手率0.06%，振幅0.84%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223228a25f04bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223228a25f04bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HCWB","BK4539"],"gpt_icon":0},{"id":"2516634474","title":"Hcw Biologics Inc.盘中异动 股价大跌6.37%报0.356美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634474","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634474?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012293,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Hcw Biologics Inc.股票出现异动，股价急速下跌6.37%。截至发稿，该股报0.356美元/股，成交量6144股，换手率0.01%，振幅0.00%。Hcw Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223133a25d3f8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223133a25d3f8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB","BK4139","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hcwbiologics.com","stockEarnings":[{"period":"1week","weight":0.4309},{"period":"1month","weight":0.247},{"period":"3month","weight":-0.5296},{"period":"6month","weight":-0.8254},{"period":"1year","weight":-0.9386},{"period":"ytd","weight":-0.2391}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"HCW Biologics Inc.于2018年4月2日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过中断慢性、低度炎症和与年龄相关的疾病之间的联系来延长健康跨度。该公司认为，与年龄相关的慢性低度炎症或“炎症”是导致几种疾病和状况的重要因素，例如癌症、心血管疾病、糖尿病、神经退行性疾病和自身免疫性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.07168},{"month":2,"riseRate":0.6,"avgChangeRate":0.016626},{"month":3,"riseRate":0.6,"avgChangeRate":0.064687},{"month":4,"riseRate":0.25,"avgChangeRate":-0.1522},{"month":5,"riseRate":0.25,"avgChangeRate":-0.089644},{"month":6,"riseRate":0.5,"avgChangeRate":-0.08481},{"month":7,"riseRate":0.5,"avgChangeRate":0.007222},{"month":8,"riseRate":0.4,"avgChangeRate":-0.025444},{"month":9,"riseRate":0.4,"avgChangeRate":-0.08752},{"month":10,"riseRate":0.4,"avgChangeRate":0.021722},{"month":11,"riseRate":0.2,"avgChangeRate":-0.225966},{"month":12,"riseRate":0.2,"avgChangeRate":-0.149456}],"exchange":"NASDAQ","name":"HCW Biologics Inc.","nameEN":"HCW Biologics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HCW Biologics Inc.(HCWB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供HCW Biologics Inc.(HCWB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"HCW Biologics Inc.,HCWB,HCW Biologics Inc.股票,HCW Biologics Inc.股票老虎,HCW Biologics Inc.股票老虎国际,HCW Biologics Inc.行情,HCW Biologics Inc.股票行情,HCW Biologics Inc.股价,HCW Biologics Inc.股市,HCW Biologics Inc.股票价格,HCW Biologics Inc.股票交易,HCW Biologics Inc.股票购买,HCW Biologics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HCW Biologics Inc.(HCWB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供HCW Biologics Inc.(HCWB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}